De Rucci Healthy Sleep Co., Ltd.

SZSE:001323.SZ

34.38 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q1
Revenue 1,121.2491,724.8991,235.8191,413.9351,201.2541,773.0661,406.0941,442.194957.1971,659.211,401.4271,507.2651,244.7732,209.3131,462.7971,566.6071,242.325
Cost of Revenue 540.019889.092626.178721.23598.821900.313689.213689.381494.048887.796738.826800.157684.5011,207.706830.537844.314683.562
Gross Profit 581.231835.807609.642692.705602.434872.753716.881752.813463.149771.415662.601707.108560.2721,001.607632.259722.292558.762
Gross Profit Ratio 0.5180.4850.4930.490.5020.4920.510.5220.4840.4650.4730.4690.450.4530.4320.4610.45
Reseach & Development Expenses 43.76453.85953.67748.69145.86951.04360.6639.96634.08850.66636.7738.30132.55243.8549.16829.29532.767
General & Administrative Expenses 81.86-182.185219.646-45.04481.132-154.063201.994-44.30864.565-164.856204.20815.78617.533-139.28381.64361.1866.046
Selling & Marketing Expenses 286.621.481503.017343.442318.898407.089414.326335.27249.186405.911409.316351.924289.37509.993405.853405.298274.935
SG&A 368.46-160.703409.147388.664400.03253.027616.32290.962313.751241.056613.524367.709306.903370.71487.496466.478340.981
Other Expenses 12.187641.675-326.763-1.172-0.037-10.2952.3122.304-0.2444.481-1.104-2.534-0.365-0.056-1.7953.071-1.067
Operating Expenses 424.411534.83449.577438.526449.547536.666565.133458.091352.684534.149524.115475.981405.342670.171543.775506.458380.552
Operating Income 156.819300.978145.8254.179169.448355.667173.225311.085125.254296.347145.563227.212149.803333.59197.078215.286171.71
Operating Income Ratio 0.140.1740.1180.180.1410.2010.1230.2160.1310.1790.1040.1510.120.1510.0660.1370.138
Total Other Income Expenses Net -0.558-1.01428.12121.25216.52512.7142.3122.30411.85479.267-1.104-3.546-0.365-0.056-1.7953.071-1.067
Income Before Tax 156.261299.964173.922275.557169.411345.372175.537313.39125.01300.828144.459224.679149.438333.53595.283218.357170.643
Income Before Tax Ratio 0.1390.1740.1410.1950.1410.1950.1250.2170.1310.1810.1030.1490.120.1510.0650.1390.137
Income Tax Expense 38.49754.95524.7843.50328.16261.45912.91958.9223.74317.17126.16741.80325.33860.0978.6828.43634.161
Net Income 118.046245.009149.142231.928141.249283.913162.617254.47101.267283.657118.292182.875124.1273.43786.603189.921136.482
Net Income Ratio 0.1050.1420.1210.1640.1180.160.1160.1760.1060.1710.0840.1210.10.1240.0590.1210.11
EPS 0.290.6120.380.590.360.710.410.640.250.710.30.460.340.680.220.470.38
EPS Diluted 0.290.6120.380.590.360.710.410.640.250.710.30.460.340.680.220.470.38
EBITDA 159.414302.715177.079351.741244.154410.772242.532378.501190.029381.772225.403304.838170.246398.215159.964283.783207.682
EBITDA Ratio 0.1420.1750.1430.2490.2030.2320.1720.2620.1990.230.1610.2020.1370.180.1090.1810.167